Putnam Investments LLC Supernus Pharmaceuticals, Inc. Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$32.77 - $41.99 $1.62 Million - $2.07 Million
-49,331 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$30.84 - $49.51 $238,547 - $382,959
-7,735 Reduced 13.55%
49,331 $1.64 Million
Q3 2018

Nov 14, 2018
BUY
$42.7 - $56.55 $1.67 Million - $2.22 Million
39,192 Added 219.27%
57,066 $2.87 Million
Q2 2018

Aug 14, 2018
BUY
$44.1 - $59.85 $788,243 - $1.07 Million
17,874 New
17,874 $1.07 Million

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.98B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email